Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Prenetics Global Ltd Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/06/2023 RW Form RW - Registration Withdrawal Request:
09/29/2023 F-3 Form F-3 - Registration statement by foreign private issuers:
08/07/2023 SC 13D Lo Dennis Yuk Ming reports a 9.2% stake in Prenetics Global Limited
07/25/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/21/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/21/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/06/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
06/30/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/31/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/01/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/01/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/01/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
05/01/2023 6-K/A Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
03/27/2023 SC 13D/A Yeung Danny Sheng Wu reports a 13.9% stake in Prenetics Global Limited
03/27/2023 SC 13D Tzang Chi Hung Lawrence reports a 5.1% stake in Prenetics Global Limited
03/14/2023 6-K Quarterly results
Docs: "FORM 6-K",
"Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results New Business Strategy Focused on Precision Oncology"
03/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology LONDON AND HONG KONG, March 2, 2023 - Prenetics Global Limited , a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board to provide strategic input based on their scientific knowledge and clinical expertise to help guide the further development of Prenetics' diagnostic cancer genomics platform. Prenetics has been at the forefront of genomic and diagnostic testing, providing a wide range of genetic testing services to individuals and healthcare professionals around the world. The SAB includes a diverse group of highly respected experts in oncology and genomics, each with unique expertise and backgrounds in the f..."
01/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA"
01/17/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors"
12/16/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology"
12/15/2022 EFFECT Form EFFECT - Notice of Effectiveness:
12/14/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
11/30/2022 6-K Quarterly results
09/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
09/09/2022 6-K Quarterly results
08/17/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/29/2022 SC 13G Cheng Chi Kong reports a 10.5% stake in Prenetics Global Limited
06/28/2022 F-1/A Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
06/21/2022 F-1/A Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
06/10/2022 F-1/A Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
06/07/2022 SC 13G EASTSPRING INVESTMENTS LTD reports a 12.5% stake in PRENETICS GLOBAL LIMITED
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy